» Articles » PMID: 17889719

Cytotoxicity of NF-kappaB Inhibitors Bay 11-7085 and Caffeic Acid Phenethyl Ester to Ramos and Other Human B-lymphoma Cell Lines

Overview
Journal Exp Hematol
Specialty Hematology
Date 2007 Sep 25
PMID 17889719
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The viability of normal and malignant B-cells was shown to depend on the constitutive activation of the nuclear factor (NF)- kappaB pathway. Thus, attempts to find efficient inhibitors of NF-kappaB play a central role in the search for novel anti-B lymphoma therapies. We studied the effects of two NF-kappaB inhibitors, Bay 11-7085 (BAY) and caffeic acid phenethyl ester (CAPE), on the viability of B-lymphoma cell lines.

Methods: We investigated the mechanism(s) of the cytotoxic effect of the NF-kappaB inhibitors, BAY, and CAPE on human-lymphoma and nonhematological cell lines.

Results: BAY and CAPE were shown to kill Ramos-Burkitt's lymphoma cells with IC(50) values of 0.7 microM and 4 microM, respectively. The rapid killing by BAY (h) vs the slower killing by CAPE (1-3 days), and their differential effects on the stages of the cell cycle, indicated that these drugs induce killing by different mechanisms. BAY and CAPE induced a loss of the cytoplasmic compartment and generated pyknotic nuclei, which lacked nuclear or nucleosomal fragmentation, features characteristic of necrosis rather than apoptosis. BAY also induced a rapid loss of the mitochondrial potential and rapid inhibition of p65 NF-kappaB binding to its kappaB motif without reducing the level of nuclear p65.

Conclusion: Our results indicate that BAY causes a necrotic rather than apoptotic cell death, either through its effect on the NF-kappaB pathway and/or by affecting additional molecular targets. The high sensitivity of B-lymphoma cell lines to the cytotoxicity of BAY, justify further research to explore its potential therapeutic effect on human B lymphomas.

Citing Articles

GSK3β/NF-κB -dependent transcriptional regulation of homeostatic hepatocyte production.

Grayck M, McCarthy W, Solar M, Golden E, Balasubramaniyan N, Zheng L Am J Physiol Gastrointest Liver Physiol. 2024; 326(4):G374-G384.

PMID: 38193163 PMC: 11211040. DOI: 10.1152/ajpgi.00229.2023.


Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.

de Klerk D, de Keijzer M, Dias L, Heemskerk J, de Haan L, Kleijn T Methods Mol Biol. 2022; 2451:405-480.

PMID: 35505025 DOI: 10.1007/978-1-0716-2099-1_20.


High-Throughput Screening to Identify Inhibitors of Importin α.

Walunj S, Dias M, Kaur C, Wagstaff K, Dey V, Hick C Cells. 2022; 11(7).

PMID: 35406765 PMC: 8997399. DOI: 10.3390/cells11071201.


Immune-Stimulatory Effects of Curcumin on the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma.

Kotting C, Hofmann L, Lotfi R, Engelhardt D, Laban S, Schuler P Cancers (Basel). 2021; 13(6).

PMID: 33809574 PMC: 8001767. DOI: 10.3390/cancers13061335.


The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells.

Yang H, Xiang S, Kazi A, Sebti S J Biol Chem. 2020; 295(10):3055-3063.

PMID: 32001619 PMC: 7062149. DOI: 10.1074/jbc.RA119.011930.